OTCMKTS:RCDTF

Recordati Industria Chimica e Farmaceutica Competitors

$53.65
0.00 (0.00 %)
(As of 04/12/2021 12:00 AM ET)
Add
Compare
Today's Range
$53.65
Now: $53.65
$53.65
50-Day Range
$51.69
MA: $53.05
$53.65
52-Week Range
$36.50
Now: $53.65
$55.87
VolumeN/A
Average Volume8,400 shs
Market Capitalization$11.22 billion
P/E Ratio25.79
Dividend YieldN/A
Beta0.3

Competitors

Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF) Vs. BCMXY, HENKY, MURGY, SUHJY, SWGAY, and SMCAY

Should you be buying RCDTF stock or one of its competitors? Companies in the industry of "private households" are considered alternatives and competitors to Recordati Industria Chimica e Farmaceutica, including Bank of Communications (BCMXY), Henkel AG & Co. KGaA (HENKY), Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (MURGY), Sun Hung Kai Properties (SUHJY), The Swatch Group (SWGAY), and SMC (SMCAY).

Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF) and Bank of Communications (OTCMKTS:BCMXY) are both large-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, analyst recommendations, risk, dividends and valuation.

Profitability

This table compares Recordati Industria Chimica e Farmaceutica and Bank of Communications' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Recordati Industria Chimica e Farmaceutica26.35%34.63%15.31%
Bank of Communications15.51%8.48%0.62%

Analyst Ratings

This is a summary of current ratings and target prices for Recordati Industria Chimica e Farmaceutica and Bank of Communications, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Recordati Industria Chimica e Farmaceutica02002.00
Bank of Communications00103.00

Earnings & Valuation

This table compares Recordati Industria Chimica e Farmaceutica and Bank of Communications' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Recordati Industria Chimica e Farmaceutica$1.64 billion6.84$413.08 million$1.9827.09
Bank of Communications$60.07 billion0.74$11.18 billionN/AN/A

Bank of Communications has higher revenue and earnings than Recordati Industria Chimica e Farmaceutica.

Risk & Volatility

Recordati Industria Chimica e Farmaceutica has a beta of 0.3, meaning that its share price is 70% less volatile than the S&P 500. Comparatively, Bank of Communications has a beta of 0.31, meaning that its share price is 69% less volatile than the S&P 500.

Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF) and Henkel AG & Co. KGaA (OTCMKTS:HENKY) are both large-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, analyst recommendations, risk, dividends and valuation.

Insider & Institutional Ownership

0.1% of Henkel AG & Co. KGaA shares are owned by institutional investors. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Profitability

This table compares Recordati Industria Chimica e Farmaceutica and Henkel AG & Co. KGaA's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Recordati Industria Chimica e Farmaceutica26.35%34.63%15.31%
Henkel AG & Co. KGaAN/AN/AN/A

Analyst Ratings

This is a summary of current ratings and target prices for Recordati Industria Chimica e Farmaceutica and Henkel AG & Co. KGaA, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Recordati Industria Chimica e Farmaceutica02002.00
Henkel AG & Co. KGaA16502.33

Earnings & Valuation

This table compares Recordati Industria Chimica e Farmaceutica and Henkel AG & Co. KGaA's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Recordati Industria Chimica e Farmaceutica$1.64 billion6.84$413.08 million$1.9827.09
Henkel AG & Co. KGaA$22.53 billion1.97$2.34 billion$1.5116.75

Henkel AG & Co. KGaA has higher revenue and earnings than Recordati Industria Chimica e Farmaceutica. Henkel AG & Co. KGaA is trading at a lower price-to-earnings ratio than Recordati Industria Chimica e Farmaceutica, indicating that it is currently the more affordable of the two stocks.

Volatility and Risk

Recordati Industria Chimica e Farmaceutica has a beta of 0.3, suggesting that its stock price is 70% less volatile than the S&P 500. Comparatively, Henkel AG & Co. KGaA has a beta of 0.7, suggesting that its stock price is 30% less volatile than the S&P 500.

Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF) and Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (OTCMKTS:MURGY) are both large-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, analyst recommendations, risk, dividends and valuation.

Insider & Institutional Ownership

0.2% of Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München shares are owned by institutional investors. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Profitability

This table compares Recordati Industria Chimica e Farmaceutica and Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Recordati Industria Chimica e Farmaceutica26.35%34.63%15.31%
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München2.19%4.05%0.42%

Analyst Ratings

This is a summary of current ratings and target prices for Recordati Industria Chimica e Farmaceutica and Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Recordati Industria Chimica e Farmaceutica02002.00
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München14602.45

Earnings & Valuation

This table compares Recordati Industria Chimica e Farmaceutica and Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Recordati Industria Chimica e Farmaceutica$1.64 billion6.84$413.08 million$1.9827.09
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München$61.62 billion0.72$3.05 billionN/AN/A

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München has higher revenue and earnings than Recordati Industria Chimica e Farmaceutica.

Volatility and Risk

Recordati Industria Chimica e Farmaceutica has a beta of 0.3, suggesting that its stock price is 70% less volatile than the S&P 500. Comparatively, Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München has a beta of 0.98, suggesting that its stock price is 2% less volatile than the S&P 500.

Summary

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München beats Recordati Industria Chimica e Farmaceutica on 7 of the 11 factors compared between the two stocks.

Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF) and Sun Hung Kai Properties (OTCMKTS:SUHJY) are both large-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, analyst recommendations, risk, dividends and valuation.

Insider & Institutional Ownership

0.1% of Sun Hung Kai Properties shares are owned by institutional investors. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Profitability

This table compares Recordati Industria Chimica e Farmaceutica and Sun Hung Kai Properties' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Recordati Industria Chimica e Farmaceutica26.35%34.63%15.31%
Sun Hung Kai PropertiesN/AN/AN/A

Analyst Ratings

This is a summary of current ratings and target prices for Recordati Industria Chimica e Farmaceutica and Sun Hung Kai Properties, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Recordati Industria Chimica e Farmaceutica02002.00
Sun Hung Kai Properties00103.00

Earnings & Valuation

This table compares Recordati Industria Chimica e Farmaceutica and Sun Hung Kai Properties' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Recordati Industria Chimica e Farmaceutica$1.64 billion6.84$413.08 million$1.9827.09
Sun Hung Kai Properties$10.66 billion4.15$3.04 billion$1.3111.65

Sun Hung Kai Properties has higher revenue and earnings than Recordati Industria Chimica e Farmaceutica. Sun Hung Kai Properties is trading at a lower price-to-earnings ratio than Recordati Industria Chimica e Farmaceutica, indicating that it is currently the more affordable of the two stocks.

Volatility and Risk

Recordati Industria Chimica e Farmaceutica has a beta of 0.3, suggesting that its stock price is 70% less volatile than the S&P 500. Comparatively, Sun Hung Kai Properties has a beta of 0.81, suggesting that its stock price is 19% less volatile than the S&P 500.

Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF) and The Swatch Group (OTCMKTS:SWGAY) are both large-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, analyst recommendations, risk, dividends and valuation.

Profitability

This table compares Recordati Industria Chimica e Farmaceutica and The Swatch Group's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Recordati Industria Chimica e Farmaceutica26.35%34.63%15.31%
The Swatch GroupN/AN/AN/A

Analyst Ratings

This is a summary of current ratings and target prices for Recordati Industria Chimica e Farmaceutica and The Swatch Group, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Recordati Industria Chimica e Farmaceutica02002.00
The Swatch Group16502.33

Earnings & Valuation

This table compares Recordati Industria Chimica e Farmaceutica and The Swatch Group's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Recordati Industria Chimica e Farmaceutica$1.64 billion6.84$413.08 million$1.9827.09
The Swatch Group$8.30 billion5.31$734.74 millionN/AN/A

The Swatch Group has higher revenue and earnings than Recordati Industria Chimica e Farmaceutica.

Risk & Volatility

Recordati Industria Chimica e Farmaceutica has a beta of 0.3, meaning that its share price is 70% less volatile than the S&P 500. Comparatively, The Swatch Group has a beta of 0.74, meaning that its share price is 26% less volatile than the S&P 500.

Summary

The Swatch Group beats Recordati Industria Chimica e Farmaceutica on 5 of the 9 factors compared between the two stocks.

Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF) and SMC (OTCMKTS:SMCAY) are both large-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, analyst recommendations, risk, dividends and valuation.

Profitability

This table compares Recordati Industria Chimica e Farmaceutica and SMC's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Recordati Industria Chimica e Farmaceutica26.35%34.63%15.31%
SMC20.08%8.17%7.34%

Analyst Ratings

This is a summary of current ratings and target prices for Recordati Industria Chimica e Farmaceutica and SMC, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Recordati Industria Chimica e Farmaceutica02002.00
SMC01102.50

Insider & Institutional Ownership

0.8% of SMC shares are owned by institutional investors. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Volatility and Risk

Recordati Industria Chimica e Farmaceutica has a beta of 0.3, suggesting that its stock price is 70% less volatile than the S&P 500. Comparatively, SMC has a beta of 0.99, suggesting that its stock price is 1% less volatile than the S&P 500.

Earnings & Valuation

This table compares Recordati Industria Chimica e Farmaceutica and SMC's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Recordati Industria Chimica e Farmaceutica$1.64 billion6.84$413.08 million$1.9827.09
SMC$4.84 billion8.46$1.02 billion$0.7639.97

SMC has higher revenue and earnings than Recordati Industria Chimica e Farmaceutica. Recordati Industria Chimica e Farmaceutica is trading at a lower price-to-earnings ratio than SMC, indicating that it is currently the more affordable of the two stocks.

Summary

SMC beats Recordati Industria Chimica e Farmaceutica on 8 of the 12 factors compared between the two stocks.

pixel
Ad Resource Stock Digest
100X Gains On Tap as Under-the-Radar Green-Tech Stock Soars
Searching for the next 1,000% stock winner? Look no further than key Green-Techs that are driving the EV, Solar & 5G booms. Silver is the #1 element in the Green Energy Revolution & we’ve found the top silver gem – undiscovered at 10-cents per share – that’s fueling the path to a carbon-free world.

Recordati Industria Chimica e Farmaceutica Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Bank of Communications logo
BCMXY
Bank of Communications
1.2$15.01flat$44.59 billion$60.07 billion4.77
Henkel AG & Co. KGaA logo
HENKY
Henkel AG & Co. KGaA
1.4$25.29flat$44.30 billion$22.53 billion18.73Analyst Revision
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München logo
MURGY
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München
0.6$31.57flat$44.23 billion$61.62 billion32.55News Coverage
Sun Hung Kai Properties logo
SUHJY
Sun Hung Kai Properties
1.4$15.26flat$44.22 billion$10.66 billion11.65News Coverage
The Swatch Group logo
SWGAY
The Swatch Group
0.5$15.10flat$44.05 billion$8.30 billion0.00
SMC logo
SMCAY
SMC
1.3$30.38flat$40.93 billion$4.84 billion42.79
China Shenhua Energy logo
CSUAY
China Shenhua Energy
1.3$8.18flat$40.65 billion$35.00 billion7.43
Vestas Wind Systems A/S logo
VWDRY
Vestas Wind Systems A/S
1.2$64.08flat$38.83 billion$13.61 billion72.82Ex-Dividend
Gap Up
Compass Group logo
CMPGY
Compass Group
0.8$21.65flat$38.62 billion$25.75 billion90.21Analyst Downgrade
Sands China logo
SCHYY
Sands China
0.9$46.73flat$37.81 billion$8.81 billion18.62
Flutter Entertainment logo
PDYPY
Flutter Entertainment
0.4$104.66flat$36.65 billion$2.73 billion54.80Analyst Report
Kuehne + Nagel International logo
KHNGY
Kuehne + Nagel International
0.9$59.58flat$35.67 billion$21.23 billion44.13
Seven & i logo
SVNDY
Seven & i
1.6$20.13flat$35.61 billion$61.13 billion21.42Gap Down
Sandvik AB (publ) logo
SDVKY
Sandvik AB (publ)
0.8$28.01flat$35.14 billion$10.92 billion52.85Upcoming Earnings
Japan Tobacco logo
JAPAY
Japan Tobacco
1.2$9.47flat$33.59 billion$19.96 billion12.46
Experian logo
EXPGY
Experian
1.1$36.54flat$33.52 billion$5.18 billion35.82
H & M Hennes & Mauritz AB (publ) logo
HNNMY
H & M Hennes & Mauritz AB (publ)
0.7$4.58flat$33.45 billion$24.63 billion152.67Upcoming Earnings
Techtronic Industries logo
TTNDY
Techtronic Industries
0.2$88.65flat$32.50 billion$7.67 billion0.00Gap Up
Amadeus IT Group logo
AMADY
Amadeus IT Group
0.5$69.61flat$31.36 billion$6.25 billion-240.03
ASSA ABLOY AB (publ) logo
ASAZY
ASSA ABLOY AB (publ)
1.2$14.84flat$31.30 billion$9.95 billion36.18
Fujitsu logo
FJTSY
Fujitsu
0.9$30.47flat$30.88 billion$35.49 billion23.08
CK Hutchison logo
CKHUY
CK Hutchison
0.7$7.95flat$30.64 billion$38.34 billion0.00
Swire Pacific logo
SWRAY
Swire Pacific
1.6$7.87flat$30.59 billion$10.93 billion3.14
Ashtead Group logo
ASHTY
Ashtead Group
1.2$254.23flat$28.56 billion$5.84 billion35.11
Sampo Oyj logo
SAXPY
Sampo Oyj
0.8$23.99flat$26.87 billion$12.62 billion18.74
Associated British Foods logo
ASBFY
Associated British Foods
0.9$33.82flat$26.77 billion$18.00 billion32.21Analyst Upgrade
Compagnie Générale des Établissements Michelin Société en commandite par actions logo
MGDDY
Compagnie Générale des Établissements Michelin Société en commandite par actions
1.5$29.78flat$26.56 billion$27.03 billion13.72Analyst Downgrade
News Coverage
Zalando logo
ZLNDY
Zalando
0.4$50.68flat$25.87 billion$7.26 billion230.37Analyst Upgrade
Gap Up
Wilmar International logo
WLMIY
Wilmar International
0.7$40.93flat$25.86 billion$42.64 billion20.06
Sunny Optical Technology (Group) logo
SNPTF
Sunny Optical Technology (Group)
0.5$22.95flat$25.17 billion$5.48 billion0.00
Unicharm logo
UNICY
Unicharm
0.9$8.40flat$24.94 billion$6.55 billion64.62
UniCredit logo
UNCFF
UniCredit
1.2$10.62flat$23.79 billion$25.52 billion11.06
Kerry Group logo
KRYAY
Kerry Group
1.2$132.46flat$23.41 billion$8.11 billion30.04Gap Up
China CITIC Bank logo
CHCJY
China CITIC Bank
0.9$9.38flat$22.95 billion$47.62 billion0.00
CIADY
China Mengniu Dairy
0.9$57.53flat$22.71 billion$11.44 billion37.85
Shimano logo
SMNNY
Shimano
0.5$24.47flat$22.68 billion$3.33 billion41.84Gap Down
SGS logo
SGSOY
SGS
1.3$29.56flat$22.36 billion$6.64 billion33.21
BAE Systems logo
BAESY
BAE Systems
1.4$27.78flat$22.36 billion$22.52 billion13.62Dividend Increase
Analyst Downgrade
Ocado Group logo
OCDDY
Ocado Group
0.4$59.00flat$22.09 billion$2.26 billion-77.63Gap Up
Sysmex logo
SSMXY
Sysmex
0.6$51.14flat$21.42 billion$2.78 billion77.48
Suzuki Motor logo
SZKMY
Suzuki Motor
1.5$173.05flat$21.24 billion$32.03 billion20.53Analyst Downgrade
Gap Up
Sino Biopharmaceutical logo
SBMFF
Sino Biopharmaceutical
0.8$1.06flat$19.92 billion$3.51 billion0.00
Secom logo
SOMLY
Secom
1.3$21.31flat$19.89 billion$9.75 billion25.99News Coverage
Nomura Research Institute logo
NRILY
Nomura Research Institute
1.1$30.81flat$19.74 billion$4.87 billion36.25
Eisai logo
ESALY
Eisai
1.3$66.38flat$19.69 billion$6.40 billion17.15
Ferrovial logo
FRRVY
Ferrovial
0.5$26.20flat$19.20 billion$6.78 billion0.00
Rakuten logo
RKUNY
Rakuten
0.6$12.17flat$19.17 billion$11.60 billion-19.95
Eurofins Scientific logo
ERFSF
Eurofins Scientific
0.9$102.67flat$18.28 billion$5.19 billion45.43
Deutsche Wohnen logo
DWHHF
Deutsche Wohnen
0.9$48.28flat$17.37 billion$937.88 million14.12
Chow Tai Fook Jewellery Group logo
CJEWY
Chow Tai Fook Jewellery Group
1.2$16.98flat$16.98 billion$7.26 billion45.89News Coverage
This page was last updated on 4/12/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.